Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1997 Aug;151(2):343–351.

The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.

S Pittaluga 1, I Wlodarska 1, K Pulford 1, E Campo 1, S W Morris 1, H Van den Berghe 1, C De Wolf-Peeters 1
PMCID: PMC1858018  PMID: 9250148

Abstract

Anaplastic large cell lymphoma (ALCL) is a heterogeneous group of diseases by morphology, phenotype, genotype, and clinical presentation. Using a new monoclonal antibody (ALK1) that recognizes the native anaplastic lymphoma kinase (ALK) protein as well as the fusion product of the t(2;5)(p23;q35), nucleophosmin (NPM)/ALK, we investigated for ALK expression cases diagnosed as ALCL as well as lympho-proliferative disorders possessing overlapping features with ALCL. Thirteen cases showed cytoplasmic staining of the neoplastic cells. These cases were characterized by a fairly uniform morphology and occurred in children and young adults as a systemic disease. All other cases comprising T or null ALCL (17 cases), B ALCL (8 cases), Hodgkin's disease (HD) (15 cases), HD-like ALCL (23 cases), and lymphomatoid papulosis (9 cases), were negative for ALK expression. Translocation t(2;5)(p23;q35) was found by classical cytogenetics or interphase fluorescence in situ hybridization in 8 of the ALK1-positive cases and by reverse transcription-polymerase chain reaction in 1 other case. Two additional ALK1-positive cases with an abnormal karyotype, but without t(2;5)(p23;q35), showed by fluorescence in situ hybridization analysis a cryptic NPM/ALK gene fusion caused by an insertion of ALK near NPM in one case and a translocation of ALK to 2q35 as a result of an indiscernible inv(2)(p23q35) in the other. The latter variant translocation points to a localization of an unknown gene at 2q35 that, like NPM, might deregulate ALK and be involved in the pathogenesis of ALCL. In summary, immunohistochemistry with ALK1 antibody allows the identification of a distinct subgroup within the ALCL of T or null phenotype that is associated with 2p23 abnormalities and lacks the marked histological pleomorphism described in ALCL in general. Whereas immunostaining is the most sensitive method to identify this group, it does not help to additionally clarify the relationship among ALCL, HD, and HD-like ALCL.

Full text

PDF
347

Images in this article

346Figure 1
on p.346
348Figure 2
on p.348
349Figure 3
on p.349

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnarsson B. A., Kadin M. E. Ki-1 positive large cell lymphoma. A morphologic and immunologic study of 19 cases. Am J Surg Pathol. 1988 Apr;12(4):264–274. doi: 10.1097/00000478-198804000-00002. [DOI] [PubMed] [Google Scholar]
  2. Arber D. A., Sun L. H., Weiss L. M. Detection of the t(2;5)(p23;q35) chromosomal translocation in large B-cell lymphomas other than anaplastic large cell lymphoma. Hum Pathol. 1996 Jun;27(6):590–594. doi: 10.1016/s0046-8177(96)90167-7. [DOI] [PubMed] [Google Scholar]
  3. Beljaards R. C., Kaudewitz P., Berti E., Gianotti R., Neumann C., Rosso R., Paulli M., Meijer C. J., Willemze R. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients. Cancer. 1993 Mar 15;71(6):2097–2104. doi: 10.1002/1097-0142(19930315)71:6<2097::aid-cncr2820710626>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  4. Chott A., Kaserer K., Augustin I., Vesely M., Heinz R., Oehlinger W., Hanak H., Radaszkiewicz T. Ki-1-positive large cell lymphoma. A clinicopathologic study of 41 cases. Am J Surg Pathol. 1990 May;14(5):439–448. doi: 10.1097/00000478-199005000-00003. [DOI] [PubMed] [Google Scholar]
  5. DeCoteau J. F., Butmarc J. R., Kinney M. C., Kadin M. E. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood. 1996 Apr 15;87(8):3437–3441. [PubMed] [Google Scholar]
  6. Delsol G., Al Saati T., Gatter K. C., Gerdes J., Schwarting R., Caveriviere P., Rigal-Huguet F., Robert A., Stein H., Mason D. Y. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. Am J Pathol. 1988 Jan;130(1):59–70. [PMC free article] [PubMed] [Google Scholar]
  7. Downing J. R., Shurtleff S. A., Zielenska M., Curcio-Brint A. M., Behm F. G., Head D. R., Sandlund J. T., Weisenburger D. D., Kossakowska A. E., Thorner P. Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood. 1995 Jun 15;85(12):3416–3422. [PubMed] [Google Scholar]
  8. Ebrahim S. A., Ladanyi M., Desai S. B., Offit K., Jhanwar S. C., Filippa D. A., Lieberman P. H., Chaganti R. S. Immunohistochemical, molecular, and cytogenetic analysis of a consecutive series of 20 peripheral T-cell lymphomas and lymphomas of uncertain lineage, including 12 Ki-1 positive lymphomas. Genes Chromosomes Cancer. 1990 May;2(1):27–35. doi: 10.1002/gcc.2870020106. [DOI] [PubMed] [Google Scholar]
  9. Elmberger P. G., Lozano M. D., Weisenburger D. D., Sanger W., Chan W. C. Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions. Blood. 1995 Nov 1;86(9):3517–3521. [PubMed] [Google Scholar]
  10. Falini B., Pileri S., Pizzolo G., Dürkop H., Flenghi L., Stirpe F., Martelli M. F., Stein H. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood. 1995 Jan 1;85(1):1–14. [PubMed] [Google Scholar]
  11. Frizzera G. The distinction of Hodgkin's disease from anaplastic large cell lymphoma. Semin Diagn Pathol. 1992 Nov;9(4):291–296. [PubMed] [Google Scholar]
  12. Golub T. R., Barker G. F., Lovett M., Gilliland D. G. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell. 1994 Apr 22;77(2):307–316. doi: 10.1016/0092-8674(94)90322-0. [DOI] [PubMed] [Google Scholar]
  13. Hagemeijer A., Buijs A., Smit E., Janssen B., Creemers G. J., Van der Plas D., Grosveld G. Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia. Genes Chromosomes Cancer. 1993 Dec;8(4):237–245. doi: 10.1002/gcc.2870080406. [DOI] [PubMed] [Google Scholar]
  14. Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994 Sep 1;84(5):1361–1392. [PubMed] [Google Scholar]
  15. Herbst H., Anagnostopoulos J., Heinze B., Dürkop H., Hummel M., Stein H. ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease. Blood. 1995 Sep 1;86(5):1694–1700. [PubMed] [Google Scholar]
  16. Kaneko Y., Frizzera G., Edamura S., Maseki N., Sakurai M., Komada Y., Sakurai M., Tanaka H., Sasaki M., Suchi T. A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood. 1989 Feb 15;73(3):806–813. [PubMed] [Google Scholar]
  17. Kinney M. C., Collins R. D., Greer J. P., Whitlock J. A., Sioutos N., Kadin M. E. A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. Am J Surg Pathol. 1993 Sep;17(9):859–868. doi: 10.1097/00000478-199309000-00001. [DOI] [PubMed] [Google Scholar]
  18. Ladanyi M., Cavalchire G., Morris S. W., Downing J., Filippa D. A. Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease. Am J Pathol. 1994 Dec;145(6):1296–1300. [PMC free article] [PubMed] [Google Scholar]
  19. Lamant L., Meggetto F., al Saati T., Brugières L., de Paillerets B. B., Dastugue N., Bernheim A., Rubie H., Terrier-Lacombe M. J., Robert A. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood. 1996 Jan 1;87(1):284–291. [PubMed] [Google Scholar]
  20. Leoncini L., Del Vecchio M. T., Kraft R., Megha T., Barbini P., Cevenini G., Poggi S., Pileri S., Tosi P., Cottier H. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study. Am J Pathol. 1990 Nov;137(5):1047–1057. [PMC free article] [PubMed] [Google Scholar]
  21. Lopategui J. R., Sun L. H., Chan J. K., Gaffey M. J., Frierson H. F., Jr, Glackin C., Weiss L. M. Low frequency association of the t(2;5)(p23;q35) chromosomal translocation with CD30+ lymphomas from American and Asian patients. A reverse transcriptase-polymerase chain reaction study. Am J Pathol. 1995 Feb;146(2):323–328. [PMC free article] [PubMed] [Google Scholar]
  22. Mason D. Y., Bastard C., Rimokh R., Dastugue N., Huret J. L., Kristoffersson U., Magaud J. P., Nezelof C., Tilly H., Vannier J. P. CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35. Br J Haematol. 1990 Feb;74(2):161–168. doi: 10.1111/j.1365-2141.1990.tb02560.x. [DOI] [PubMed] [Google Scholar]
  23. Mathew P., Sanger W. G., Weisenburger D. D., Valentine M., Valentine V., Pickering D., Higgins C., Hess M., Cui X., Srivastava D. K. Detection of the t(2;5)(p23;q35) and NPM-ALK fusion in non-Hodgkin's lymphoma by two-color fluorescence in situ hybridization. Blood. 1997 Mar 1;89(5):1678–1685. [PubMed] [Google Scholar]
  24. Morris S. W., Kirstein M. N., Valentine M. B., Dittmer K. G., Shapiro D. N., Saltman D. L., Look A. T. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science. 1994 Mar 4;263(5151):1281–1284. doi: 10.1126/science.8122112. [DOI] [PubMed] [Google Scholar]
  25. Orscheschek K., Merz H., Hell J., Binder T., Bartels H., Feller A. C. Large-cell anaplastic lymphoma-specific translocation (t[2;5] [p23;q35]) in Hodgkin's disease: indication of a common pathogenesis? Lancet. 1995 Jan 14;345(8942):87–90. doi: 10.1016/s0140-6736(95)90061-6. [DOI] [PubMed] [Google Scholar]
  26. Pallesen G., Hamilton-Dutoit S. J. Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma. Am J Pathol. 1988 Dec;133(3):446–450. [PMC free article] [PubMed] [Google Scholar]
  27. Pileri S., Falini B., Delsol G., Stein H., Baglioni P., Poggi S., Martelli M. F., Rivano M. T., Mason D. Y., Stansfeld A. G. Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1 + with a high content of reactive histiocytes). Histopathology. 1990 Apr;16(4):383–391. doi: 10.1111/j.1365-2559.1990.tb01143.x. [DOI] [PubMed] [Google Scholar]
  28. Pulford K., Lamant L., Morris S. W., Butler L. H., Wood K. M., Stroud D., Delsol G., Mason D. Y. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood. 1997 Feb 15;89(4):1394–1404. [PubMed] [Google Scholar]
  29. Rosso R., Paulli M., Magrini U., Kindl S., Boveri E., Volpato G., Poggi S., Baglioni P., Pileri S. Anaplastic large cell lymphoma, CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen. Immunohistochemical and morphological relationships to Hodgkin's disease. Virchows Arch A Pathol Anat Histopathol. 1990;416(3):229–235. doi: 10.1007/BF01678982. [DOI] [PubMed] [Google Scholar]
  30. Sainati L., Montaldi A., Stella M., Putti M. C., Zanesco L., Basso G. A novel variant translocation t(2;13) (p23;q34) in Ki-1 large cell anaplastic lymphoma. Br J Haematol. 1990 Aug;75(4):621–622. doi: 10.1111/j.1365-2141.1990.tb07812.x. [DOI] [PubMed] [Google Scholar]
  31. Sandlund J. T., Pui C. H., Santana V. M., Mahmoud H., Roberts W. M., Morris S., Raimondi S., Ribeiro R., Crist W. M., Lin J. S. Clinical features and treatment outcome for children with CD30+ large-cell non-Hodgkin's lymphoma. J Clin Oncol. 1994 May;12(5):895–898. doi: 10.1200/JCO.1994.12.5.895. [DOI] [PubMed] [Google Scholar]
  32. Sarris A. H., Luthra R., Papadimitracopoulou V., Waasdorp M., Dimopoulos M. A., McBride J. A., Cabanillas F., Duvic M., Deisseroth A., Morris S. W. Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis. Blood. 1996 Sep 1;88(5):1771–1779. [PubMed] [Google Scholar]
  33. Shiota M., Fujimoto J., Takenaga M., Satoh H., Ichinohasama R., Abe M., Nakano M., Yamamoto T., Mori S. Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood. 1994 Dec 1;84(11):3648–3652. [PubMed] [Google Scholar]
  34. Shiota M., Nakamura S., Ichinohasama R., Abe M., Akagi T., Takeshita M., Mori N., Fujimoto J., Miyauchi J., Mikata A. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood. 1995 Sep 1;86(5):1954–1960. [PubMed] [Google Scholar]
  35. Smith C. A., Gruss H. J., Davis T., Anderson D., Farrah T., Baker E., Sutherland G. R., Brannan C. I., Copeland N. G., Jenkins N. A. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell. 1993 Jul 2;73(7):1349–1360. doi: 10.1016/0092-8674(93)90361-s. [DOI] [PubMed] [Google Scholar]
  36. Stein H., Mason D. Y., Gerdes J., O'Connor N., Wainscoat J., Pallesen G., Gatter K., Falini B., Delsol G., Lemke H. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985 Oct;66(4):848–858. [PubMed] [Google Scholar]
  37. Weisenburger D. D., Gordon B. G., Vose J. M., Bast M. A., Chan W. C., Greiner T. C., Anderson J. R., Sanger W. G. Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma. Blood. 1996 May 1;87(9):3860–3868. [PubMed] [Google Scholar]
  38. Weiss L. M., Lopategui J. R., Sun L. H., Kamel O. W., Koo C. H., Glackin C. Absence of the t(2;5) in Hodgkin's disease. Blood. 1995 May 15;85(10):2845–2847. [PubMed] [Google Scholar]
  39. Wellmann A., Otsuki T., Vogelbruch M., Clark H. M., Jaffe E. S., Raffeld M. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. Blood. 1995 Sep 15;86(6):2321–2328. [PubMed] [Google Scholar]
  40. Wlodarska I., De Wolf-Peeters C., Michaux L., Mecucci C., Verhoef G., Cassiman J. J., Van den Berghe H. A new t(2;5) translocation in a null cell type CD30 positive anaplastic large cell lymphoma case. Leukemia. 1995 Oct;9(10):1685–1688. [PubMed] [Google Scholar]
  41. Yee H. T., Ponzoni M., Merson A., Goldstein M., Scarpa A., Chilosi M., Menestrina F., Pittaluga S., de Wolf-Peeters C., Shiota M. Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease. Blood. 1996 Feb 1;87(3):1081–1088. [PubMed] [Google Scholar]
  42. de Bruin P. C., Beljaards R. C., van Heerde P., Van Der Valk P., Noorduyn L. A., Van Krieken J. H., Kluin-Nelemans J. C., Willemze R., Meijer C. J. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathology. 1993 Aug;23(2):127–135. doi: 10.1111/j.1365-2559.1993.tb00470.x. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES